Pluristem Therapeutics Inc.
PSTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $6 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $16 | $0 | $0 |
| Total Curr. Assets | $17 | $22 | $0 | $0 |
| Property Plant & Equip (Net) | $9 | $9 | $0 | $0 |
| Goodwill | $3 | $3 | $0 | $0 |
| Intangibles | $3 | $3 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$15 | -$20 | $0 | $0 |
| Total NC Assets | -$0 | -$6 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17 | $17 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $30 | $4 | $3 |
| Total Curr. Liab. | $32 | $32 | $6 | $4 |
| LT Debt | $6 | $6 | $6 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $20 | $20 |
| Total NC Liab. | $6 | $7 | $26 | $25 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $7 | $31 | $29 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$449 | -$443 | -$435 | -$429 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $438 | $436 | $431 | $421 |
| Total Equity | -$11 | -$7 | -$4 | -$8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $6 | $5 | $5 |
| Total Liab. & Tot. Equity | -$4 | $0 | $27 | $21 |
| Net Debt | $2 | $1 | $6 | $5 |